# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-026010
Filing Date
2024-05-14
Accepted
2024-05-14 17:14:58
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ef20026296_10q.htm iXBRL | 10-Q | 1136285
2 | EXHIBIT 31.1 | ef20026296_ex31-1.htm | EX-31.1 | 6561
3 | EXHIBIT 31.2 | ef20026296_ex31-2.htm | EX-31.2 | 6540
4 | EXHIBIT 32.1 | ef20026296_ex32-1.htm | EX-32.1 | 3879
5 | EXHIBIT 32.2 | ef20026296_ex32-2.htm | EX-32.2 | 3862
11 |  | image00007.jpg | GRAPHIC | 2588
| Complete submission text file | 0001140361-24-026010.txt |  | 6339467

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | erna-20240331.xsd | EX-101.SCH | 58210
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | erna-20240331_cal.xml | EX-101.CAL | 50587
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | erna-20240331_def.xml | EX-101.DEF | 281249
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | erna-20240331_lab.xml | EX-101.LAB | 682592
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | erna-20240331_pre.xml | EX-101.PRE | 423812
80 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20026296_10q_htm.xml | XML | 823180

Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 24945696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)